scyllo-inositol is an investigational drug.
There have been 4 clinical trials for scyllo-inositol.
The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2012.
The most common disease conditions in clinical trials are Alzheimer Disease, Disease, and Psychomotor Agitation. The leading clinical trial sponsors are OPKO Health, Inc., Transition Therapeutics Ireland Limited, and Transition Therapeutics.